Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.1%

1 terminated/withdrawn out of 47 trials

Success Rate

96.9%

+10.4% vs industry average

Late-Stage Pipeline

19%

9 trials in Phase 3/4

Results Transparency

13%

4 of 31 completed trials have results

Key Signals

7 recruiting4 with results

Enrollment Performance

Analytics

N/A

18(52.9%)

Phase 3

7(20.6%)

Phase 2

4(11.8%)

Phase 1

3(8.8%)

Phase 4

2(5.9%)

34Total

N/A(18)

Phase 3(7)

Phase 2(4)

Phase 1(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (47)

Showing 20 of 47 trials

NCT06958198Phase 1Recruiting

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

Role: collaborator

NCT07183371Phase 2Active Not Recruiting

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Role: collaborator

NCT06100146Not ApplicableCompleted

Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls

Role: collaborator

NCT07074665Phase 2Recruiting

Dose Finding Trial of R21/Matrix-M in School Children

Role: collaborator

NCT04704830Phase 3Active Not Recruiting

R21/Matrix-M in African Children Against Clinical Malaria

Role: collaborator

NCT06912620Phase 3Recruiting

Alternative RUTFs for Treatment of Child Wasting

Role: collaborator

NCT04300309Phase 2Terminated

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria

Role: collaborator

NCT05754658Recruiting

African Cancer Genome: GMD

Role: collaborator

NCT05378880Not ApplicableCompleted

Optimising Community Antibiotic Use and Infection Control With Behavioural Interventions in Burkina Faso and DR Congo

Role: collaborator

NCT03896724Phase 1Completed

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Role: collaborator

NCT06973200Completed

Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso

Role: collaborator

NCT06759493Recruiting

Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren

Role: lead

NCT05790889Phase 1Recruiting

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Role: collaborator

NCT06792370Not ApplicableNot Yet Recruiting

Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition

Role: lead

NCT04816461Phase 4Completed

Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates

Role: lead

NCT03074435Phase 3Completed

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

Role: collaborator

NCT06444555Not ApplicableCompleted

Adolescent Nutrition in Girls in Burkina Faso and Ethiopia

Role: collaborator

NCT04319380Phase 3Completed

Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study

Role: collaborator

NCT05285657Not ApplicableCompleted

Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases.

Role: lead

NCT06094049Recruiting

Acceptability of Folic Acid and Vitamin B12 Fortified Meals

Role: collaborator